# Infection-Related Glomerulonephritis

Infection-related glomerulonephritis requires prompt recognition of a nephritic urine sediment, identification and eradication of active infection, volume and blood-pressure control, and kidney biopsy when rapidly progressive injury or competing immune glomerular disease would change treatment.

**Clinical question:** How should physicians distinguish, evaluate, and manage infection-related glomerulonephritis while avoiding inappropriate immunosuppression?

Updated: 2026-08-21T01:59:45.968545+00:00

## What matters in practice
- Treat a nephritic sediment with rising creatinine as an urgent glomerular process: quantify proteinuria, examine fresh urine for dysmorphic erythrocytes and red-cell casts, and assess kidney function and volume status. [9][10]
- Active or occult infection must be sought before immunosuppression, particularly when IgA-dominant glomerulonephritis could represent staphylococcal infection-associated disease rather than primary IgA nephropathy. [18][21]
- Kidney biopsy is pivotal when rapidly progressive glomerulonephritis, severe acute kidney injury, nephrotic-range proteinuria, uncertain infection status, or serologic overlap leaves immunosuppressive treatment under consideration. Biopsy immunofluorescence separates immune-complex, pauci-immune, anti-GBM, C3-dominant, and monoclonal immunoglobulin-associated patterns. [8][19]
- For bacterial infection-related glomerulonephritis, eradicate the infection and achieve source control while managing hypervolemia, hypertension, and kidney dysfunction; corticosteroids are contraindicated in IgA-dominant staphylococcal disease. [20][21][23]
- Adults have substantially less favorable renal outcomes than children: residual hypertension or chronic kidney disease occurs in 30% to 50% after poststreptococcal disease, and sustained chronic kidney disease has been reported in up to 77% with staphylococcal infection-associated glomerulonephritis. [20]

## Triage nephritic AKI and establish glomerular involvement

Prioritize pulmonary edema, severe hypertension, oliguria, hyperkalemia, and rapidly rising creatinine before assigning an etiology.

Obtain serum creatinine, electrolytes, albumin, complete blood count, C-reactive protein, urinalysis with microscopy, and quantitative proteinuria at presentation. Use a fresh urine specimen for sediment examination because storage damages erythrocytes; red-cell casts, dysmorphic erythrocytes, and proteinuria exceeding 500 mg/day favor glomerular bleeding. [10]

Treat red-cell casts plus a rising serum creatinine as a crescentic glomerulonephritis warning pattern requiring expedited nephrology involvement and kidney biopsy planning. Acute nephritic syndrome or rapidly progressive glomerulonephritis is particularly associated with infection-related GN, ANCA-associated vasculitis, and anti-GBM disease, so infection cannot be presumed to be the sole explanation. [8][10]

Perform a directed examination for active infection and systemic mimics: fever, cardiac murmur or embolic findings, infected skin or wound lesions, indwelling hardware, pulmonary symptoms, purpura, arthralgia, neuropathy, and upper-airway disease. Skin and other organ-system findings help distinguish kidney-limited disease from systemic glomerular disorders. [9][10]
- If the infectious source is not evident, consider transesophageal echocardiography for endocarditis and CT imaging for an occult abscess. [10]
- Obtain HIV and hepatitis B and C testing when risk factors are present; chronic hepatitis C is a cause of immune-complex/MPGN-pattern glomerulonephritis and may overlap clinically with infection-related disease. [8][10]
- Send ANCA and anti-GBM antibodies promptly in rapidly progressive disease; ANCA testing and biopsy assist diagnosis of ANCA-associated vasculitis, for which immunosuppressive induction differs fundamentally from infection-directed management. [2]

*Initial features that direct urgent branching in suspected infection-related glomerulonephritis. [8][9][10]*

| Finding | Interpretation | Immediate next action |
| --- | --- | --- |
| Fresh urine with red-cell casts, dysmorphic erythrocytes, and proteinuria >500 mg/day | Supports glomerular hematuria rather than lower-tract bleeding. [10] | Quantify proteinuria, trend creatinine and potassium, and initiate glomerulonephritis serologic and infection evaluation. [10] |
| Rising creatinine with red-cell casts | Suggests crescentic GN and possible rapidly progressive kidney injury. [10] | Expedite nephrology consultation, serologies, and kidney biopsy assessment. [2][10] |
| Possible occult bacterial focus | Endocarditis or deep abscess can drive persistent immune-complex glomerular injury. [10][21] | Use transesophageal echocardiography or CT when clinical assessment does not identify the source. [10] |
| Pulmonary, skin, neurologic, or upper-airway vasculitic findings | Raises ANCA-associated vasculitis or anti-GBM disease alongside infection-related GN. [2][8] | Send ANCA and anti-GBM antibodies and obtain biopsy without delaying stabilization. [2][8] |

## Use infection timing, clinical context, and pathology to separate major branches

An infection-associated nephritic presentation may be poststreptococcal, ongoing staphylococcal disease, endocarditis-associated disease, or a noninfectious mimic.

Poststreptococcal GN classically follows rather than accompanies infection, with a latency after apparent clinical recovery. In contrast, infection-related GN in adults commonly accompanies active infection, and staphylococcal infection is a leading adult trigger. Infection-related GN can follow bacterial, viral, or parasitic infections. [5][20][23]

Staphylococcal infection-associated GN with glomerular IgA deposition is a high-stakes mimic of primary IgA nephropathy. Features favoring infection-associated disease are a concurrent staphylococcal infection, acute renal failure, and often massive proteinuria; gross hematuria after an upper respiratory infection is more characteristic of IgA nephropathy. Search for occult infection before considering immunosuppression for an apparent IgA nephropathy presentation. [18][21]

Endocarditis-associated GN should remain prominent when nephritic urinary abnormalities coexist with constitutional symptoms, cardiac findings, embolic phenomena, or unexplained inflammation. Infection eradication with antibiotics for 4 to 6 weeks usually corrects serologic abnormalities, although microscopic hematuria, proteinuria, and elevated creatinine can persist for months. [21]

C3-dominant infection-related GN and C3 glomerulopathy can have similar biopsy appearances. Infection-related disease is often preceded by infection and improves after infection resolution; persistent hematuria or proteinuria after a biopsy pattern of postinfectious GN should prompt evaluation for alternative-pathway complement abnormalities and possible C3 glomerulopathy. [13][19]

### Pathology that changes the treatment pathway

Kidney biopsy should include light microscopy, immunofluorescence, and electron microscopy when the diagnosis is uncertain or renal injury is severe. Typical postinfectious GN combines proliferative glomerulonephritis on light microscopy, bright C3 staining with or without immunoglobulins on immunofluorescence, and subepithelial hump-like deposits on electron microscopy. [19]

Immunofluorescence provides the central etiologic branch point: immune-complex GN includes infection-related GN, IgA nephropathy, lupus nephritis, and cryoglobulinemic GN; pauci-immune GN suggests ANCA-associated disease; linear anti-GBM disease and C3 glomerulopathy require distinct evaluation and treatment. [8]

An MPGN pattern is not itself a diagnosis. Chronic hepatitis C, cryoglobulinemia, lupus nephritis, and alternative-complement pathway abnormalities can produce overlapping proliferative or MPGN-pattern injury; direct further testing toward the immunofluorescence pattern and clinical context. [8][12]
- In cryoglobulinemic GN, low or undetectable C4, cryoglobulins, and a monoclonal gammopathy can support the diagnosis; biopsy may show intracapillary hyaline pseudothrombi and glomerular basement membrane duplication. [12]
- In ANCA-associated vasculitis, a typical clinical presentation plus PR3-ANCA or MPO-ANCA can support the diagnosis, but biopsy remains recommended to establish the diagnosis when feasible. [2]

*Etiologic distinctions in an infection-associated nephritic presentation. [2][8][18][19][21]*

| Branch | Discriminators | Management implication |
| --- | --- | --- |
| Poststreptococcal GN | Occurs after infection and a latent period after return toward baseline health. [9][23] | Manage volume, hypertension, and kidney dysfunction; address the antecedent streptococcal infection when present. [20] |
| Staphylococcal infection-associated, often IgA-dominant GN | Concurrent staphylococcal infection, acute renal failure, and frequent massive proteinuria distinguish it from primary IgA nephropathy. [21] | Use antibiotics and source control; corticosteroids are contraindicated. [21] |
| Endocarditis-associated GN | Persistent infection context with nephritic abnormalities; occult cases merit transesophageal echocardiography. [10][21] | Treat endocarditis with 4-6 weeks of antibiotics; renal urinary abnormalities may resolve slowly. [21] |
| C3 glomerulopathy or atypical postinfectious GN | Persistent hematuria/proteinuria after apparent postinfectious GN and alternative-pathway abnormalities; C3-dominant pathology may overlap. [13][19] | Do not assume infection alone explains persistent disease; assess alternative complement pathway abnormalities. [19] |
| ANCA-associated vasculitis or anti-GBM disease | Rapidly progressive GN, systemic vasculitic features, ANCA or anti-GBM serology, and biopsy pattern. [2][8] | Requires urgent disease-specific immunosuppression rather than infection-only management. [2] |

## Escalate to kidney biopsy when treatment choices diverge

The practical indication is not diagnostic curiosity: biopsy is needed when its pattern will determine whether immunosuppression is harmful, necessary, or avoidable.

Proceed urgently to kidney biopsy in rapidly progressive glomerulonephritis, unexplained acute kidney injury with active urine sediment, severe proteinuria, or when ANCA-associated vasculitis, anti-GBM disease, C3 glomerulopathy, cryoglobulinemia, lupus nephritis, or infection-related GN remain plausible. The same diffuse proliferative pattern can result from acute infection, lupus nephritis, or cryoglobulinemia, whereas immunofluorescence can classify the process by its deposits. [8]

Do not treat a positive ANCA result as sufficient proof that infection is absent or that vasculitis is the sole driver. ANCA-associated vasculitis may be supported by a typical clinical presentation plus PR3-ANCA or MPO-ANCA, and EULAR recommends both ANCA testing and biopsy to assist diagnosis. [2]

A biopsy showing crescents during active infection creates a management conflict. Pulse corticosteroids and plasma exchange have been used alongside effective antibiotics in crescentic endocarditis-associated GN, but their added value is undefined; in IgA-dominant staphylococcal GN, corticosteroids are contraindicated. [21]
- Request light microscopy, immunofluorescence, and electron microscopy rather than relying on a single modality when postinfectious GN is suspected. [19]
- If biopsy demonstrates persistent postinfectious-pattern disease with ongoing hematuria or proteinuria, investigate alternative-pathway complement abnormalities rather than escalating empiric immunosuppression. [19]

*Biopsy patterns with immediate interpretive consequences. [8][19][12]*

| Biopsy result | Etiologic interpretation | Next diagnostic direction |
| --- | --- | --- |
| Proliferative GN, bright C3 with or without immunoglobulin, subepithelial humps | Typical postinfectious GN pattern. [19] | Confirm and eradicate infection; if urinary abnormalities persist, assess alternative complement pathway abnormalities. [19] |
| Immune-complex GN | Includes infection-related GN, IgA nephropathy, lupus nephritis, and cryoglobulinemic GN. [8] | Integrate infection assessment with autoimmune, viral hepatitis, and cryoglobulin evaluation. [8][10] |
| Pauci-immune necrotizing/crescentic GN | Supports ANCA-associated GN when clinical and serologic context fits. [2][8] | Apply AAV-directed induction strategy after excluding or concurrently treating infection. [2] |
| MPGN with hyaline pseudothrombi and basement membrane duplication | Supports cryoglobulinemic GN in the appropriate serologic setting. [12] | Evaluate cryoglobulins and monoclonal immunoglobulin-associated disease. [12] |

## Treat the infection and renal complications in parallel

In bacterial infection-related GN, infection eradication and source control are the disease-modifying interventions.

Initiate pathogen-directed antimicrobial therapy and source control once infection is identified or strongly suspected, while managing hypervolemia, hypertension, and kidney dysfunction. This framework applies across poststreptococcal, staphylococcal, other bacterial, viral, and parasitic infection-related GN, although the specific anti-infective regimen must follow the pathogen and source. [20]

Use fluid and sodium restriction when hypervolemia is present, and monitor daily weight, blood pressure, urine output, creatinine, potassium, and bicarbonate during acute kidney injury. Escalate renal replacement therapy for standard kidney-failure complications when medical management does not control volume, electrolyte, acid-base, or uremic consequences; dialysis-requiring kidney injury is reported in severe infection-related GN. [20][24]

Avoid corticosteroids for IgA-dominant staphylococcus-related GN: antibiotic treatment is indicated because renal recovery may occur, whereas corticosteroid therapy is contraindicated. This distinction is the principal reason to establish whether IgA deposition reflects infection-associated GN or primary IgA nephropathy. [21]

For endocarditis-associated GN, effective antibiotics for 4 to 6 weeks usually eradicate infection and correct serologic abnormalities. Do not interpret persistent microscopic hematuria, proteinuria, or elevated creatinine in the first months after microbiologic cure as automatic treatment failure; these abnormalities may resolve gradually. [21]
- Use infection-source investigation as a treatment intervention: evaluate suspected endocarditis with transesophageal echocardiography and occult abscess with CT when no focus is apparent. [10]
- Reserve immunosuppressive therapy for a biopsy- and clinical-context-supported noninfectious immune process or for selected severe overlap presentations after multidisciplinary assessment; its benefit in crescentic infection-associated GN is uncertain. [2][21][23]
- In life-threatening or organ-threatening ANCA-associated vasculitis, recommended remission induction is high-dose glucocorticoids plus rituximab or cyclophosphamide; this is not a regimen for unconfirmed infection-related GN. [2]

*Treatment priorities by infection-related glomerulonephritis scenario. [20][21][23]*

| Clinical scenario | Primary action | Avoid or qualify |
| --- | --- | --- |
| Bacterial infection-related GN with identifiable focus | Administer pathogen-directed antibiotics, achieve source control, and treat hypervolemia, hypertension, and kidney dysfunction. [20][23] | Do not substitute empiric immunosuppression for infection eradication. [23] |
| IgA-dominant staphylococcal GN | Treat the staphylococcal infection; renal recovery may follow antibiotic therapy. [21] | Corticosteroids are contraindicated. [21] |
| Endocarditis-associated GN | Treat endocarditis with 4-6 weeks of antibiotics. [21] | Crescentic-disease corticosteroids or plasma exchange have uncertain added value. [21] |
| Crescentic GN with diagnostic uncertainty | Expedite biopsy and ANCA/anti-GBM testing while treating any active infection. [2][8] | Do not delay AAV-specific induction when organ-threatening AAV is established. [2] |

## Monitor renal recovery after infection control and identify persistent disease

Clinical improvement should be judged by kidney function, urinary activity, blood pressure, and evidence that the infection is controlled.

Follow creatinine, estimated kidney function, urine protein, hematuria, blood pressure, and volume status after treatment. In endocarditis-associated GN, C3 normalization during therapy correlates with a good outcome, while urinary abnormalities and creatinine elevation may persist for months despite infection eradication. [21]

Persistent hematuria and proteinuria after a postinfectious biopsy pattern should trigger reassessment rather than passive observation. In atypical postinfectious GN, persistent urinary abnormalities for 4 to 48 months were associated with alternative-pathway complement abnormalities; this phenotype may overlap with C3 glomerulopathy. [19]

Counsel adult patients that renal prognosis is materially worse than in children. After poststreptococcal GN, residual hypertension and chronic kidney disease may occur in 30% to 50% of adults; with staphylococcal infection-associated GN, sustained chronic kidney disease has been reported in up to 77%. Prognosis depends on pathogen, baseline kidney function, rapidly progressive presentation, and timing of treatment. [20]
- Recheck for persistent or recurrent infection if creatinine rises, urinary sediment becomes more active, inflammatory features recur, or complement fails to improve in a context where it previously tracked recovery. [21]
- Revisit the diagnosis and obtain complement-pathway assessment when proteinuria or hematuria persists after apparent infection resolution. [13][19]

*Post-treatment monitoring signals and responses. [19][20][21]*

| Monitoring result | Interpretation | Response |
| --- | --- | --- |
| Improving creatinine, blood pressure, edema, and urine findings | Compatible with renal recovery after infection control. [20][21] | Continue serial kidney-function and urinary monitoring. [20] |
| Persistent microscopic hematuria, proteinuria, or creatinine elevation after endocarditis treatment | May persist for months after eradication. [21] | Trend renal parameters and verify infection control before labeling treatment failure. [21] |
| Persistent hematuria/proteinuria after postinfectious-pattern biopsy | Raises atypical postinfectious GN or alternative-pathway complement dysregulation. [19] | Evaluate alternative complement pathway abnormalities and reconsider C3 glomerulopathy. [13][19] |
| Adult staphylococcal infection-associated GN | High risk of sustained chronic kidney disease, reported up to 77%. [20] | Arrange long-term CKD and hypertension surveillance. [20] |

## References
1. Twelve to Seventeen-Year Follow-up of Patients with ... — www.nejm.org — https://www.nejm.org/doi/abs/10.1056/NEJM198209163071205
2. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update | Annals of the Rheumatic Diseases — ard.bmj.com — https://ard.bmj.com/content/83/1/30
3. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience | Journal for ImmunoTherapy of Cancer — jitc.bmj.com — https://jitc.bmj.com/content/7/1/2
4. Revolutionizing Autoimmune Kidney Disease Treatment ... — spj.science.org — https://spj.science.org/doi/10.34133/research.0712
5. The Influence and Role of Microbial Factors in Autoimmune ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1155/2015/858027
6. Focal Segmental Glomerulosclerosis With Superimposed ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1002/ccr3.9593
7. Infection Related Glomerulonephritis Associated with ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1155/2014/130624
8. Acute glomerulonephritis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0140673622004615
9. Membranoproliferative Glomerulonephritis - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/neuroscience/membranoproliferative-glomerulonephritis
10. Leukocyturia - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/leukocyturia
11. POSTER PRESENTATION : Indian Journal of Nephrology — journals.lww.com — https://journals.lww.com/ijon/fulltext/2022/32001/poster_presentation.2.aspx
12. Cryoglobulinemic Glomerulonephritis in the... : Journal of the American Society of Nephrology — journals.lww.com — https://journals.lww.com/jasn/pdf/10.1681/asn.20233411s1785d~cryoglobulinemic-glomerulonephritis-in-the-setting-of
13. 627 C3 glomerulonephritis and C3-dominant infection related ... — academic.oup.com — https://academic.oup.com/ndt/article/39/Supplement_1/gfae069-0328-627/7678552
14. case reports and review of the literature | Clinical Kidney Journal — academic.oup.com — https://academic.oup.com/ckj/article/4/3/181/345193
15. Eculizumab for rapidly progressive glomerulonephritis in ... — academic.oup.com — https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfag128/8709289
16. Post-infectious glomerulonephritis with crescents in adults — academic.oup.com — https://academic.oup.com/ckj/article/9/2/222/2462454
17. Staphylococcal Infections in Children:Part 11 — pedsinreview.aappublications.org — https://pedsinreview.aappublications.org/content/20/6/183
18. IgA nephropathy | Cleveland Clinic Journal of medicine — www.ccjm.org — https://www.ccjm.org/content/90/6_suppl_1/e5
19. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement — www.kidney-international.org — https://www.kidney-international.org/article/S0085-2538(15)55730-X/fulltext
20. Infection-Related Glomerulonephritis - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK538255
21. Glomerular Diseases Associated with Infection — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7151996
22. Staphylococcus-Induced Glomerulonephritis Following Burn ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12412335
23. Management of immune-mediated glomerular diseases in the elderly — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11463022
24. Management and outcomes of acute post-streptococcal glomerulonephritis in children — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9521512

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.